The studies reported here were conducted to investigate the effectiven
ess of doramectin, given intramuscularly at the rate of 300 mu gkg(-1)
of bodyweight, in the treatment of naturally acquired porcine nematod
osis and acariasis. Twenty pigs demonstrated to be naturally infected
with pulmonary and gastrointestinal nematodes were used in one control
study, and 22 pigs demonstrated to be naturally parasitized with Sarc
optes scabiei var. suis were used in a second study. In both studies,
animals were evenly divided between doramectin plus vehicle and vehicl
e-treated groups by restricted randomization. In the anthelmintic stud
y, all pigs were necropsied for parasite collection on post-treatment
Days 14 and 15. The acaricidal evaluation study was 28 days in duratio
n after treatment, with mite population quantifications on the day of
treatment and on post-treatment Days 7, 14, 21 and 28. Doramectin prov
ed 100% effective in the removal of Metastrongylus salmi, M. elongatus
, M. pudendotectus, Strongyloides ransomi, Ascaris suum and Oesophagos
tomum dentatum. Levels of Hyostrongylus rubidus. Ascarops strongylina
and Macracanthorhynchus hirudinaceus, as observed at necropsy in the d
oramectin-treated pigs, were reduced by 99.2%, 99.5% and 62.1%, respec
tively, as compared with levels seen in the control pigs. In regard to
Sarcoptes scabiei var. suis, no live mites were recovered from dorame
ctin-treated pigs during the 7-28 day post-treatment period. In conclu
sion, doramectin proved highly effective in the treatment of naturally
acquired porcine nematodosis and Sarcoptes scabiei var. suis infestat
ion. In addition, all treatments were safe and well tolerated, with no
adverse reactions noted in any trial animals. (C) 1997 Elsevier Scien
ce B.V.